4,971
edits
no edit summary
No edit summary |
|||
| Line 11: | Line 11: | ||
Dye, K. M., Feudtner, C., Post, D., & Vogt, E. M. (1999). Developing Collaborative Leadership to Reframe the Safe Use of Pharmaceuticals as a National Health Priority. Final Report, CWA Ltd. | Dye, K. M., Feudtner, C., Post, D., & Vogt, E. M. (1999). Developing Collaborative Leadership to Reframe the Safe Use of Pharmaceuticals as a National Health Priority. Final Report, CWA Ltd. | ||
Dye, K. M., Post, D., & Vogt, E. (1999). Developing a Consensus on the Accountability and Responsibility for the Safe Use of Pharmaceuticals. Washington, DC: The National Patient Safety Foundation. | |||
Krieg EJ, Faber DR, Steinemann A, Daughton CG, Montague P, Bailey D, Solomon G, Warner JC, Cannon AS, Dye KM, Tickner JA. Environmental Impact Assessment Review. | |||
Palihapitiya, M., & Dye, K. (2008). Democracy in Practice: Lessons from New England. | |||